Navigation Links
Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
Date:4/2/2009

y in clinical trials. Labopharm believes that it is likely that the results of this trial are insufficient to support the acceptance of a New Drug Application (NDA) by the Food and Drug Administration (FDA) in the United States. The Company intends to discuss the matter with the FDA's Division of Anesthesia, Analgesia & Rheumatology Products (DAARP) to determine the path forward. The results of this study are however statistically significant under analyses that the Company believes may be accepted for the evaluation of analgesics in Europe, Canada and other jurisdictions. Accordingly, the Company intends to meet with the regulatory authorities for these jurisdictions at the earliest available opportunity in pursuit of regulatory approval. Should the authorities be in agreement, the Company expects that it would submit a regulatory application in those jurisdictions.

The Company will provide additional information following discussions with the various regulatory authorities.

The results of the study have no bearing on the upcoming launch of the Company's once-daily tramadol product in the United States.

About Tramadol-Acetaminophen Combination Products

Tramadol-acetaminophen products leverage the unique but complementary modes of action of each of the active ingredients to provide the analgesic strength of a mild opioid (tramadol) and the rapid pain relief of acetaminophen. Tramadol-acetaminophen combination products were first launched in 2001 in the United States and in 2003 in other major markets and are indicated for the short-term (five days or less) management of acute pain in the U.S. and the symptomatic treatment of moderate to severe pain in the rest of the world.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique o
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Visitors to the Radiometer booth (#331) at the ... have the opportunity to learn from the company’s experts ... host two sessions of each presentation at the following ... Plan (IQCP) for Blood Gas Testing, Tuesday, July 29, ... Clinical and Scientific Affairs Manager, Radiometer America , The ...
(Date:7/22/2014)... July 22, 2014 BlackBox Biometrics, Inc. ... Gauge™ System with advancements including a new ... gauges represent a functional revision of the already robust ... capture complex data on blast events by recording a ... The extreme changes in overpressure that accompany a blast ...
(Date:7/22/2014)... 22, 2014 Eating certain foods can not ... well, according to two of the world’s top cosmetic ... Reshad of the Anacapa Dental Art Institute in Oxnard and ... care of one’s teeth. They are specially trained to replace ... are not seeing a dentist regularly, and about two-thirds of ...
(Date:7/22/2014)... Alan Tonelson of Riverdale Park, Md. ... most kids outgrow the inhibiting speech condition by the ... the three million people in the U.S. who live ... Throughout his youth, he participated in a variety of ... with private speech-and-language pathologists. None helped him achieve fluency. ...
(Date:7/22/2014)... Recently, 2014quinceaneradresses.com, a popular online shop of women’s ... blue and white Quinceanera dresses . Moreover, the ... gowns, hoping to show appreciation to the international clients. ... discounted price, up to 60% off. , Its ... items. As one of the leaders in the fashion ...
Breaking Medicine News(10 mins):Health News:Radiometer Features Booth Presentations On IQCP and Blood Gas Preanalytics at the 2014 AACC Clinical Lab Expo 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 3Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 2Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 3Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 4Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 5Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Blue and White Quinceanera Dresses at Low Prices Offered by 2014quinceaneradresses.com 2
... , CHICAGO, Sept. 1 In ... which shows young athletes with repeated brain injuries are at ... Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch ... and monitoring concussions. The complimentary card is an educational tool ...
... , , , FRANKLIN LAKES, N.J., Sept. 1 ... announced today that it would present at the following investor healthcare conferences in September: , ... September 9, 2009, ... Conference, September 14, 2009, ...
... than laparoscopic surgery, study finds , TUESDAY, Sept. 1 ... pelvic pain by disrupting nerve connections failed to improve ... researchers say. , The nerve-disruption procedure "did not alleviate ... irrespective of the presence or absence of mild endometriosis," ...
... , , WARSAW, Ind., Sept. 1 Zimmer ... be participating in the following investor conferences during the month of September: , ... Conference 2009 in Boston, Mass., on September 9, 2009, at 11:30 a.m. Eastern ... New York, N.Y., on September 14, 2009, at 8:35 a.m. Eastern Time; and ...
... "Saturday ... Dr. Lonnie Paulos now beginning its second year , ... Gulf Breeze, FL (Vocus) September 1, 2009 -- ... orthopaedic exams and assessments to high school and collegiate athletes on Saturday mornings. ...
... , KANSAS CITY, Mo., Sept. 1 ... with medical challenges often unique to members of the military. From ... some of the most pressing conditions confronting the health care system ... Release, go to: http://www.prnewswire.com/mnr/militaryhealth/39824/ , ...
Cached Medicine News:Health News:Illinois Athletic Trainers and Physicians Offer Handy Wallet Card to Tackle Concussions 'Head On' 2Health News:Two Treatments Equally Effective for Chronic Pelvic Pain 2Health News:Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 2Health News:Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 3Health News:Video: Physical and Mental Health of U.S. Warfighter Is Focus of Military Health Research Forum 2
(Date:7/22/2014)... MARCOS, Texas , July 22, 2014 Quantum Materials ... and Mr. John Heaton to the Board of ... by Dr. Ghassan Jabbour , QMC Chief Science Officer and ... Michael Wong of Rice University and Mr. Tomio ... Japan . " Quantum Materials welcomes ...
(Date:7/22/2014)... WASHINGTON, New York , July ... Neue Partnerschaft für umfassenden Schutz ... Medikamenteneinwirkungen in Österreich    ... Anbieter von geschlossenen Transfersystemen (Closed System Transfer Devices, CSTDs) ... Medikus , einen Vertriebshändler und Hersteller ...
(Date:7/22/2014)... July 22, 2014 ... company focused on solid dose formulations of therapeutics ... formulation of octreotide acetate achieved successful results in ... currently marketed liquid product (Sandostatin®).  Based on these ... production process to a contract manufacturing organisation (CMO), ...
Breaking Medicine Technology:Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2
... Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) ... in a Phase 2 clinical trial using intravenous ... carboplatin in patients with non-small cell lung cancer ... Investigator is Dr. Miguel Villalona-Calero, Professor, Division of ...
... The following is being issued by Coast IRB: ... 2009, Coast IRB informed the public that it had discovered ... that Independent review board for evaluation. Coast IRB has ... part of a congressional "sting" operation. Apparently at the ...
Cached Medicine Technology:Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 2Congressional 'Sting' Operation Uncovered By Coast IRB 2
These retractors are packaged singly ready for sterilization at your facility....
... is a revolutionary motorized electronic pipette. ... mind, Pipetman Concept features exclusive multifunction ... only one of its kind in ... Tips from Gilson, this product will ...
Rainbow technology combines the latest in system theory, adaptive signal processing and a revolutionary sensor that employs eight wavelengths of light to collect and analyze an extraordinarily rich s...
... is a revolutionary motorized electronic pipette. ... mind, Pipetman Concept features exclusive multifunction ... only one of its kind in ... Tips from Gilson, this product will ...
Medicine Products: